AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference
MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 22nd Annual Needham Virtual Healthcare Conference.
AtriCure’s management is scheduled to participate in a fireside chat on Monday, April 17, 2023 at 1:30 pm Eastern Standard Time. Interested parties may access a live audio webcast by visiting the “Investors” section of the company’s website at https://ir.atricure.com.
About AtriCure
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230403005079/en/
Angie Wirick
AtriCure, Inc.
Chief Financial Officer
(513) 755-5334
[email protected]
Lynn Lewis or Marissa Bych
Gilmartin Group
Investor Relations
[email protected]
[email protected]
Source: AtriCure, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Catalyst by Zoho Solves The Shortfalls of Moving from Coding to Production With an Agent-Ready, Full-Stack Cloud and Built-In Governance
- FRT ROBOTICS to Supply 100 StepUp NEO Wearable Robots to the U.S., Accelerating Expansion into the North American Market
- AtriCure Inc. (ATRC) PT Raised to $60 at Piper Sandler
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Needham & Company, Twitter, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share